These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18378538)

  • 21. Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers.
    Jackson-Rose J; Del Monte J; Groman A; Dial LS; Atwell L; Graham J; O'Neil Semler R; O'Sullivan M; Truini-Pittman L; Cunningham TA; Roman-Fischetti L; Costantinou E; Rimkus C; Banavage AJ; Dietz B; Colussi CJ; Catania K; Wasko M; Schreffler KA; West C; Siefert ML; Rice RD
    Clin J Oncol Nurs; 2017 Aug; 21(4):438-445. PubMed ID: 28738039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing extravasation protocols and monitoring outcomes.
    Camp-Sorrell D
    J Intraven Nurs; 1998; 21(4):232-9. PubMed ID: 9866539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extravasation management: clinical update.
    Schulmeister L
    Semin Oncol Nurs; 2011 Feb; 27(1):82-90. PubMed ID: 21255716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.
    Sanborn RE; Sauer DA
    Dermatol Clin; 2008 Jan; 26(1):103-19, ix. PubMed ID: 18023774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reader looking for guidelines/policies on continuous infusion vesicants for assessments.
    Parran L
    Oncol Nurs Forum; 2000 Sep; 27(8):1201-2. PubMed ID: 11013900
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations for Management of Noncytotoxic Vesicant Extravasations.
    Ong J; Van Gerpen R
    J Infus Nurs; 2020; 43(6):319-343. PubMed ID: 33141794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extravasation of chemotherapeutic agents: prevention and treatment.
    Goolsby TV; Lombardo FA
    Semin Oncol; 2006 Feb; 33(1):139-43. PubMed ID: 16473651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of extravasation of chemotherapeutic agents].
    Yamamoto A
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1750-2. PubMed ID: 22083178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eliminating extravasation events: a multidisciplinary approach.
    Coyle CE; Griffie J; Czaplewski LM
    J Infus Nurs; 2014; 37(3):157-64. PubMed ID: 24694509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing cytotoxic extravasation.
    Pattison J
    Nurs Times; 2002 Oct 29-Nov 4; 98(44):32-4. PubMed ID: 12451746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasations.
    Steiert A; Hille U; Burke W; Gohritz A; Zilz S; Herold C; Vogt PM
    J Plast Reconstr Aesthet Surg; 2011 Feb; 64(2):240-7. PubMed ID: 20542747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extravasation of cytostatic agents--what is a good treatment?].
    Dahl BH; Rindal R
    Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1830-3. PubMed ID: 7638831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospital.
    Adami NP; de Gutiérrez MG; da Fonseca SM; de Almeida EP
    J Clin Nurs; 2005 Aug; 14(7):876-82. PubMed ID: 16000102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of perivascular extravasation of cytostatic agents].
    Rauh J; Pluntke S; Müller Ch
    MMW Fortschr Med; 2004 Aug; 146(31-32):23-4, 26-7. PubMed ID: 15529703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthracycline extravasations: prevention and management.
    Roe H
    Br J Nurs; 2011 Sep 22-Oct 13; 20(17):S16, S18-22. PubMed ID: 22067533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can you recognize the risk factors for vesicant extravasation?
    Oestreicher P
    ONS Connect; 2007 Jan; 22(1):22-3. PubMed ID: 17393637
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological management of anticancer agent extravasation: A single institutional guideline.
    Kimmel J; Fleming P; Cuellar S; Anderson J; Haaf CM
    J Oncol Pharm Pract; 2018 Mar; 24(2):129-138. PubMed ID: 29284352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report.
    Harrold K; Gould D; Drey N
    Eur J Cancer Care (Engl); 2013 Mar; 22(2):169-78. PubMed ID: 23320981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic therapy emergencies.
    Albanell J; Baselga J
    Semin Oncol; 2000 Jun; 27(3):347-61. PubMed ID: 10864222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.